Status:

COMPLETED

Pelvic Floor Muscle Training in Female CrossFit and Functional Fitness Exercisers

Lead Sponsor:

Norwegian School of Sport Sciences

Conditions:

Stress Urinary Incontinence

Pelvic Floor Disorders

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

There is a high prevalence of urinary incontinence (UI) among female athletes and exercisers, especially in sports including high impact activities and heavy weightlifting. CrossFit and functional fit...

Detailed Description

BACKGROUND: Physical activity and exercise have well-known beneficial effects on several physical and psychological health outcomes. However, it has been proposed that regular participation in physic...

Eligibility Criteria

Inclusion

  • Age ≥18
  • ≥ 6 months of consistent participation in CrossFit or functional fitness training
  • Participating in ≥ 3 sessions of cross-fit training per week
  • Self-reported SUI and a total score on ICIQ-UI-SF of ≥ 3. A change of the ICIQ-UI-SF score of 2.5 has been identified to be the minimal important difference (MID) and 1.58 as between-treatment MID (Nystrom et al., 2015).
  • No musculoskeletal injuries for the past 6 months with negative effect on training participation

Exclusion

  • Ongoing pregnancy, or planning to get pregnant during the intervention period
  • History of hysterectomy or pelvic surgery to correct UI or POP
  • History of musculoskeletal injuries for the past 6 months with negative effect on training participation
  • Parous women who are ≤12 months post-partum

Key Trial Info

Start Date :

May 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 19 2023

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT05341024

Start Date

May 2 2022

End Date

April 19 2023

Last Update

March 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Norwegian School of Sport Sciences, Department of Sport Medicine

Oslo, Norway, 0863